Metabolon Awarded Patent in Metabolomics Methods for Drug Discovery

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics, biomarker discovery and biochemical analysis, announces that it was awarded US Patent 7,910,301 “Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics” by the United States Patent and Trademark Office on March 22, 2011. This is the ninth patent to issue from the fundamental Daouk-Kristal “metabolomics methods” patent family.

Back to news